Compared with that in the infection-only and hybrid-immunity groups (7–12 months post vaccination), the proportion of SARS-CoV-2-specific CD4+ T cells in the hybrid-immunity group within 6 months post vaccination was 1.65-fold (P < 0.05) and 1.28-fold higher, respectively (Fig. 4b). Here, CD4 is linked to infection.